I'm A Patient
I'm A ProviderOver 200 Million People Live with Dry AMD Worldwide
Until now, there has never been a proven solution to improve vision loss from dry AMD. MacuMira is changing that.
Now available in Australia and New Zealand, MacuMira is a noninvasive, drug-free treatment for dry age-related macular degeneration. Clinical results showed that many patients experienced improved visual clarity after just 10 days of therapy.
Discover how MacuMira is giving people living with dry AMD a new path forward.
Learn More About MacuMira for Dry AMD
MacuMira: A New Approach to Dry AMD
Dry age-related macular degeneration (AMD) doesn’t just affect your vision; it affects your quality of life. From challenges recognising faces to the loss of independence, its impact is far-reaching.
Historically, care has focused only on slowing the progression. However, with MacuMira, a clinically supported approach is now available to help improve visual function.
MacuMira is a first-of-its-kind solution now available in Australia and New Zealand. It’s safe, noninvasive, and easy to integrate into everyday care at local eye clinics.
Your vision matters. Your quality of life matters. MacuMira is here to help.
How MacuMira Works
Microcurrent Stimulation
MacuMira delivers low-level microcurrent through the eyelids to stimulate retinal activity. This approach is grounded in decades of medical use and has been adapted for the specific needs of dry AMD.
Clinically Improved Vision
A clinical trial demonstrated that 100% of patients experienced improved visual function after receiving 6 treatments over a 30-week period. On average, patients showed improved visual acuity (as assessed by the ETDRS, which measures the number of letters read) and contrast sensitivity within 4 weeks of the first treatment. With continued treatment, vision may be maintained indefinitely.
Noninvasive & Comfortable
MacuMira does not involve injections, lasers, or surgery. Patients simply visit their eye care provider on a prescribed schedule, relax while wearing the MacuMira device for approximately half an hour, and then continue with their day.
Find a MacuMira Provider Near You for Vision-Restoring Dry AMD Treatment
MacuMira treatment is now offered in select clinics throughout Australia and New Zealand. Use our locator tool to find a provider near you, or contact us, and we’ll help you connect with one.
Download the Clinical Trial
The MacuMira clinical trial, published in the International Journal of Retina and Vitreous, found the following:
100%
of patients in the treatment group showed improved vision
48%
of patients improved by at least 10 letters on the ETDRS acuity chart
8.2 ETDRS letters
Average improvement, along with a 25% average increase in ETDRS acuity
0
adverse effects of treatment
100%
of treated patients maintained their vision improvements for the duration of the trial
Articles
Understanding how dry AMD affects you or your family member can make it a little easier to navigate. Learn more about this eye disease in our articles.
Patients
Eye Care Providers
Select your Country
Corporate:
#302, 815 – 1st Street SW
Calgary, AB
T2P 1N3
info@macumira.com
1-844-619-6263
Mailing Address:
MacuMira Medical Devices Inc
#136 1811 4th Street SW
Calgary, AB
T2S 1W2
Hours:
Mon-Fri: 8am – 5pm
Sat – Sun: Closed